
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
TriNetX has announced that Raremark has partnered with their network to bring more clinical trials to its community. Raremark builds communities of people affected by a rare condition, sharing knowledge, and collecting real-world experience.
For more information on this partnership, click






